Cargando…

Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis

(1) Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines were developed in only a short amount of time and were widely distributed. We conducted this meta-analysis to understand the safety of SARS-CoV-2 vaccines. (2) Methods: We searched the corresponding literature publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Linyi, Cai, Xianming, Zhao, Tianshuo, Han, Bingfeng, Xie, Mingzhu, Cui, Jiahao, Zhang, Jiayu, Wang, Chao, Liu, Bei, Lu, Qingbin, Cui, Fuqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030038/ https://www.ncbi.nlm.nih.gov/pubmed/35455344 http://dx.doi.org/10.3390/vaccines10040596

Ejemplares similares

What Causes the Discrepancy in SARS-CoV-2 Vaccine Between Parental Hesitancy for Themselves and for Their Children During Lockdown Period?
por: Zhao, Tianshuo, et al.
Publicado: (2023)

Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis
por: Liu, Bei, et al.
Publicado: (2022)

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study
por: Wang, Chao, et al.
Publicado: (2021)

Willingness and SARS-CoV-2 Vaccination Coverage among Healthcare Workers in China: A Nationwide Study
por: Wang, Chao, et al.
Publicado: (2021)

Analysis of deaths following yeast-derived hepatitis B vaccination of infants, China, January 2013 to December 2020
por: Zhang, Sihui, et al.
Publicado: (2023)

Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
por: Zhang, Sihui, et al.
Publicado: (2023)

Who Is the Most Vulnerable to Anxiety at the Beginning of the COVID-19 Outbreak in China? A Cross-Sectional Nationwide Survey
por: Liu, Bei, et al.
Publicado: (2021)

Trends and Factors Associated With Risk Perception, Anxiety, and Behavior From the Early Outbreak Period to the Controlled Period of COVID-19 Epidemic: Four Cross-Sectional Online Surveys in China in 2020
por: Liu, Bei, et al.
Publicado: (2022)

The Change of Public Individual Prevention Practice and Psychological Effect From the Early Outbreak Stage to the Controlled Stage of COVID-19 in China in 2020: Two Cross-Sectional Studies
por: Han, Bingfeng, et al.
Publicado: (2021)

Do Male University Students Know Enough About Human Papillomavirus (HPV) to Make Informed Decisions About Vaccination?
por: Wang, Shuai, et al.
Publicado: (2020)

12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial
por: Han, Bingfeng, et al.
Publicado: (2021)

Public Awareness, Individual Prevention Practice, and Psychological Effect at the Beginning of the COVID-19 Outbreak in China
por: Han, Bingfeng, et al.
Publicado: (2020)

Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
por: Wang, Chao, et al.
Publicado: (2022)

Immune-Boosting Effect of the COVID-19 Vaccine: Real-World Bidirectional Cohort Study
por: Liu, Ming, et al.
Publicado: (2023)

Maintaining Safety with SARS-CoV-2 Vaccines
por: Castells, Mariana C., et al.
Publicado: (2020)

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
por: Chen, Haiping, et al.
Publicado: (2022)

A Case-Control Study on Factors of HPV Vaccination for Mother and Daughter in China
por: Chen, Linyi, et al.
Publicado: (2023)

Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
por: Cao, Chao, et al.
Publicado: (2022)

SARS-CoV-2 vaccine — think globally, act locally
por: Gea-Mallorquí, Ester, et al.
Publicado: (2020)

Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis
por: Gao, Peng, et al.
Publicado: (2022)

Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2
por: Li, Jianguo, et al.
Publicado: (2020)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
por: Li, Tong, et al.
Publicado: (2022)

Global transcriptomic analysis of ethanol tolerance response in Salmonella Enteritidis
por: He, Shoukui, et al.
Publicado: (2022)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

Assessing SARS-CoV-2 vaccine hesitancy among the people living with and without HIV from May to September 2022 in Blantyre, Malawi
por: Mchawa, Chifundo, et al.
Publicado: (2023)

Safety of Inactivated SARS-CoV-2 Vaccines Among Adults with Experience of Allergies to Food or Medicines
por: Jin, Yan, et al.
Publicado: (2023)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
por: Ma, Cuiqing, et al.
Publicado: (2020)

Association between self-monitoring of blood glucose and hepatitis B virus infection among people with diabetes mellitus: a cross-sectional study in Gansu Province, China
por: Han, Bingfeng, et al.
Publicado: (2021)

Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
por: Luo, Xinyi, et al.
Publicado: (2023)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
por: Chebel, Roy, et al.
Publicado: (2021)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
por: Gursel, Mayda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fm6nk1ks0ohtvts5qtnvgohvc9